Viveka Kumar
A5114015873- Blood Pressure and Hypertension Studies
- Heart Failure Treatment and Management
- Heart Rate Variability and Autonomic Control
- Cardiac, Anesthesia and Surgical Outcomes
- Pharmaceutical studies and practices
- Venous Thromboembolism Diagnosis and Management
- Pharmaceutical Economics and Policy
- Diabetes Treatment and Management
- Cardiac Health and Mental Health
- COVID-19 Clinical Research Studies
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Pharmaceutical Practices and Patient Outcomes
- COVID-19 and healthcare impacts
- Health Systems, Economic Evaluations, Quality of Life
Max Healthcare
2024
Max Super Speciality Hospital
2023
Heart failure (HF) is a global health concern that prevalent in India as well. HF reported at younger age Indian patients with comorbidity of type 2 diabetes (T2DM) approximately 50% patients. Sodium-glucose cotransporter-2 inhibitors (SGLT2i), originally approved for T2DM, are new guideline-recommended and treatment strategies HF. Extensive evidence highlights SGLT2i exhibits profound cardiovascular (CV) benefits beyond glycemic control. SGLT2i, conjunction other guideline-directed medical...
In heart failure, sympathetic overdrive is evidenced by norepinephrine spillover, receptor level changes, etc. Beta-blockers continue to be the cornerstone of treatment in patients with chronic failure due their ability counteract overdrive. Extensive clinical research has demonstrated that long-term beta-blocker metoprolol succinate, carvedilol, or bisoprolol enhances left ventricular function and reverses remodeling, decreases hospitalization risk, increases survival. The aim this...
The incidence of heart failure (HF) in India is estimated to be 0.5-1.7 cases per 1,000 people year, and approximately 4,92,000-1.8 million new are detected every year. Despite the high rate mortality associated with HF, most patients do not receive maximal guideline-directed medical therapy (GDMT). Current guidelines advocate early multidrug combination four classes drugs, namely, beta-blockers (BBs), mineralocorticoid receptor antagonists (MRAs), angiotensin receptor-neprilysin inhibitors...
Background: Telmisartan’s low solubility limits its bioavailability, leading to poor dissolution, reduced efficacy, and decreased patient compliance. This study assesses the dissolution quality control of various commercially available 40 mg telmisartan IP tablets, all marketed as bioequivalent. Methods: The analyzed formulations containing Telmisartan. Both products Tazloc were evaluated through studies (drug release), with drug quantification performed using ultraviolet visible...
Context: The context of the study was venous thromboembolism (VTE) in coronavirus disease 2019 (COVID-19) patients. Aim: purpose to understand prevalence thrombotic events (pulmonary embolism [PE] and deep-vein thrombosis [DVT]) right ventricular (RV) dysfunction (RVD) patients with COVID-19. Settings Design: Retrospective observational study, Max Hospital, New Delhi, India. Materials Methods: This undertaken 504 diagnosed COVID-19 adult both genders age groups (>40 years 40 years) during...
Hypertension (HTN) remains one of the most important risk factors for cardiovascular (CV) diseases and a leading cause mortality worldwide. Despite improvement in detection treatment, poor blood pressure (BP) control rates are observed globally. The situation India is alarming with only 22.5% patients maintaining their BP under control. Initiating early effective treatment HTN helps within normal limits reduces associated health risks. In India, currently, there no guidelines on choice dual...